Thestra
Cancer diagnostics and therapy-stratification tools for clinicians treating head and neck cancer
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-10-28
About Thestra
Thestra develops EPLINEX®, an AI-based tissue analysis solution that helps assess cancer aggressiveness and stratify treatment for head and neck squamous cell carcinoma.
Its diagnostic tools are intended for clinicians and hospitals, supporting prognosis and therapy selection. The company is based on biomarker research conducted at the University of Turku and Turku University Hospital and is headquartered in Turku, Finland.
Product: EPLINEX®, an AI-based tissue analysis solution for assessing head and neck cancer aggressiveness and supporting therapy stratification.
Jobs at Thestra
Leadership
- Tomi Numminen · Chief Executive Officer (stepping down, effective March 6, 2026)Source: company website
More biotech & pharma companies
Uniogen
Finnish diagnostics company making cancer assay components, instruments and CDMO services for IVD and life science firmsNew on EvolcUute Scientific
Develops a Finnish biodiversity-derived microbial ingredient for skincare, health and consumer-product brandsNew on EvolcVactech
Develops vaccines and diagnostics for type 1 diabetes, celiac disease and enterovirus diseases, and licenses its patentsNew on Evolc3PBIOVIAN
Biologics CDMO providing protein, viral vector, plasmid DNA and cell therapy manufacturing for biotech and pharma companiesNew on EvolcAastat
Biostatistics and statistical programming services for pharmaceutical clients, delivered on a functional service provision modelYoung companyNew on EvolcAfekta Technologies
Metabolomics analysis of microbial and plant compounds for food manufacturers and academic researchersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Complianz
- Google Tag Manager
- LiteSpeed
- WordPress
- jQuery